174 related articles for article (PubMed ID: 16832163)
1. Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.
Barter PJ; Rye KA
Curr Opin Lipidol; 2006 Aug; 17(4):399-403. PubMed ID: 16832163
[TBL] [Abstract][Full Text] [Related]
2. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.
Nofer JR; Walter M; Assmann G
Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1071-86. PubMed ID: 16292998
[TBL] [Abstract][Full Text] [Related]
3. Multiple actions of high-density lipoprotein.
Florentin M; Liberopoulos EN; Wierzbicki AS; Mikhailidis DP
Curr Opin Cardiol; 2008 Jul; 23(4):370-8. PubMed ID: 18520722
[TBL] [Abstract][Full Text] [Related]
4. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Kontush A; Chapman MJ
Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
6. The structure, function and metabolism of high-density lipoproteins: A status report.
Levy RI; Rifkind BM
Circulation; 1980 Nov; 62(4 Pt 2):IV4-8. PubMed ID: 6998596
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein and atheroma monitoring.
Nicholls SJ; Tuzcu EM
Curr Opin Cardiol; 2008 Jul; 23(4):386-92. PubMed ID: 18520724
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein function recent advances.
Ansell BJ; Watson KE; Fogelman AM; Navab M; Fonarow GC
J Am Coll Cardiol; 2005 Nov; 46(10):1792-8. PubMed ID: 16286161
[TBL] [Abstract][Full Text] [Related]
9. Genetics of high-density lipoproteins.
Dastani Z; Engert JC; Genest J; Marcil M
Curr Opin Cardiol; 2006 Jul; 21(4):329-35. PubMed ID: 16755202
[TBL] [Abstract][Full Text] [Related]
10. The rationale for using apoA-I as a clinical marker of cardiovascular risk.
Barter PJ; Rye KA
J Intern Med; 2006 May; 259(5):447-54. PubMed ID: 16629850
[TBL] [Abstract][Full Text] [Related]
11. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease.
Packard CJ
Curr Opin Lipidol; 2006 Aug; 17(4):412-7. PubMed ID: 16832165
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of high-density lipoproteins: biochemical basis and clinical findings.
Chiesa G; Parolini C; Sirtori CR
Curr Opin Cardiol; 2008 Jul; 23(4):379-85. PubMed ID: 18520723
[TBL] [Abstract][Full Text] [Related]
13. The paradox of dysfunctional high-density lipoprotein.
Ansell BJ; Fonarow GC; Fogelman AM
Curr Opin Lipidol; 2007 Aug; 18(4):427-34. PubMed ID: 17620860
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoproteins, inflammation and oxidative stress.
Tabet F; Rye KA
Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
[TBL] [Abstract][Full Text] [Related]
15. Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?
Schaefer EJ; Asztalos BF
Curr Opin Cardiol; 2007 Jul; 22(4):373-8. PubMed ID: 17556892
[TBL] [Abstract][Full Text] [Related]
16. Targeting the anti-inflammatory effects of high-density lipoprotein.
Ansell BJ
Am J Cardiol; 2007 Dec; 100(11 A):n3-9. PubMed ID: 18047850
[TBL] [Abstract][Full Text] [Related]
17. Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.
Nofer JR; Assmann G
Trends Cardiovasc Med; 2005 Oct; 15(7):265-71. PubMed ID: 16226682
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein M--a novel player in high-density lipoprotein metabolism and atherosclerosis.
Dahlbäck B; Nielsen LB
Curr Opin Lipidol; 2006 Jun; 17(3):291-5. PubMed ID: 16680035
[TBL] [Abstract][Full Text] [Related]
19. New strategies in managing and preventing atherosclerosis: focus on HDL.
Price MJ; Shah PK
Rev Cardiovasc Med; 2002; 3(3):129-37. PubMed ID: 12439437
[TBL] [Abstract][Full Text] [Related]
20. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
Mäkelä SM; Jauhiainen M; Ala-Korpela M; Metso J; Lehto TM; Savolainen MJ; Hannuksela ML
Alcohol Clin Exp Res; 2008 Jun; 32(6):991-1000. PubMed ID: 18498551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
